NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.57 +0.01 (+0.39%)
As of: Oct 22, 2026 · 10:11 AM EDT

NeuroSense Therapeutics (NRSN) Non Operating Income (2022 - 2024)

Updated

NeuroSense Therapeutics (NRSN) posted Non Operating Income of -$46,000 for FY2025, compared with $323,000 in FY2024.

Analysis

NeuroSense Therapeutics (NRSN) Non Operating Income (2022 - 2024) Analysis & Trends

Since FY2019, NeuroSense Therapeutics has reported Non Operating Income for 7 years.

  • The FY2025 figure stands as the lowest annual Non Operating Income since FY2021.
  • Business Quant data shows NRSN's Non Operating Income at $323,000 in FY2024 (-83.4%), $1.94 million in FY2023, $62,000 in FY2022 and -$235,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn -
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn -
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn -
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn -
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn -
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn 387.00 Mn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn -
10 NeuroSense Therapeutics 3.27 Mn -1.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -30,000.00
Sep 30, 2024 -41,000.00
Jun 30, 2024 2.17 Mn
Mar 31, 2024 -2.41 Mn
Dec 31, 2023 -125,000.00
Sep 30, 2023 2.28 Mn
Jun 30, 2023 -276,000.00
Mar 31, 2023 67,000.00
Jun 30, 2022 109,000.00
Mar 31, 2022 549,000.00
API Access

NeuroSense Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=NRSN&period=max&api_key=YOUR_API_KEY